US Stem Cell Inc (USRM)

[docprep]

LIST INCOMPLETE


1. Toxic debt removed
2. Lawsuit from Northstar that could have bankrupted company settled
3. Addition of a seasoned professional on the BOD
4. Agreement with GACP to fund 10 new clinics with $500k upfront cash.
5. GACP agrees to fund Marketing costs for next 3 years (largest drain on revenues)
6. 50% increase in revenues to $3 mil in 2016
7. First time ever with positive cash on hand
8. Insider buying

Additions:

9. FDA changes will presumably make stem cell treatments easier to obtain approval.

10. Right to Try in 30+ states, and TX state law already passed with clinic opening in Dallas!!!!

11. Q2 coming out in next week or so, set to have highest revenues to date.

12. 5 revenue streams, amidst multiplying clinics.

13. Comella being consistently recognized as leader in the field.

14. News upon news upon news of stem cell treatments being utilized, successful, and cheaper than traditional medicine.